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Pulmonary calcification in hemodialyzed patients detected by
technetium-99m diphosphonate scanning. Metastatic pulmonary
calcification, a well-known complication in patients with chronic
renal disease, has been demonstrated postmortem in patients
with a negative chest X-ray. Recently, scintigrams with bone-
seeking radionuclides have been used to detect such subclinical
pulmonary calcium deposits. We describe 23 patients on mainte-
nance hemodialysis with no evidence of pulmonary calcification
on chest X-ray who were prospectively studied by lung scanning
with a bone-seeking radionuclide and pulmonary function test-
ing. Of the 23 patients, 14 (61%) had a positive technetium-99m
diphosphonate ("mTc-DP) scan (group 1). These patients were
on dialysis 38 S months compared with 12 4 months in 9
patients with a negative scan (group 2) (P < 0.01). Age, sex,
blood pressure, hematocrit, serum calcium, phosphorous, bi-
carbonate, magnesium, and calcium x phosphorus product, as
well as parathyroid hormone level did not differ between the two
groups. Of 10 group-i patients tested, 7 had abnormal pulmonary
diffusion capacity compared with none in 5 group-2 patients test-
ed (P = 0.014). Histologic examination of the lung in 1 group-i
patient who expired revealed calcification (amorphous on X-ray
diffraction), whereas none was found in 1 group-2 patient autop-
sied. These observations suggest that in patients on maintenance
hemodialysis, pulmonary scanning with a9mTcDP is a sensitive
method for detecting pulmonary metastatic calcification, which
may be associated with an abnormality in pulmonary diffusion
capacity.
Calcifications pulmonaires, chez les malades en hémodialyse,
mises en evidence par La scintigraphie au diphosphonate tech-
netium-99m. Les calcifications pulmonaires métastatiques, com-
plication bien connue chez les malades en insuffisance rCnale
chronique, ont été mises en evidence post-mortem chez des mal-
ades dont la radiographie thoracique était normale. Plus récem-
ment, des scintigraphies au moyen de radionuclides employés
pour l'imagerie osseuse ont été utilisées pour détecter de tels
dépôts pulmonaires latents de calcium. Ce travail décrit 23 ma!-
ades en hémodialyse chronique sans signes radiologiques de cal-
cifications pulmonaires qui ont été étudiés, de facon prospec-
tive, par scintigraphie pulmonaire et épreuves fonctionnelles res-
piratoires. Quatorze de ces 23 malades (61%) avaient une
scintigraphie positive au diphosphonate technetium-99m (9"Tc-
DP) (groupe 1). Ces malades étaient en dialyse depuis 38 5
mois alors que les 9 malades indemnes étaient traitCs depuis 12
4 mois (groupe 2) (P < 0,01). L'âge, le sexe, la pression ar-
térielle, l'hématocrite, la calcémie, Ia phosphorémie, les bi-
carbonates, la magnésémie, et Ic produit calcium >< phosphore,
de même que la concentration d'hormone parathyroidienne,
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n'étaient pas différents entre les deux groupes. Sept parmi les 10
malades étudiés dans le groupe 1 avaient un abaissement de Ia
capacité de diffusion qui était normale chez les 5 malades Ctudiés
dans le groupe 2 (P = 0,014). L'examen histologique du poumon
chez un malade dCcédé du groupe 1 a montrC des calcifications
(amorphes en diffraction des rayons X) alors qu'aucune n'a Cté
observée chez un malade autopsié du groupe 2. Ces con-
statations suggCrent que chez les malades en hCmodialyse Ia
scintigraphie pulmonaire avec o9mTcDP est une méthode sen-
sible pour détecter les calcifications pulmonaires, lesquelles peu-
vent &re associées a une anomalie de Ia capacité de diffusion
alvéolo-capillalre.
Metastatic pulmonary calcification is a well-
known complication in patients with chronic renal
disease [1—3]. In these reports, the diagnosis was
evident on the chest X-ray. Conger et al [4] have
demonstrated that extensive calcification may be
seen on postmortem examination of patients with
end-stage renal disease without calcification seen
on the premortem chest X-ray. Moreover, there
have been several reports in which scintigrams with
a bone-seeking radionuclide have demonstrated the
existence of pulmonary calcification in patients with
or without pulmonary calcification on chest X-ray
[5—9]. The present report describes the results of a
prospective study in which lung scans with a bone-
seeking radionuclide and pulmonary function stud-
ies were carried out in 23 patients with end-stage
renal disease on maintenance hemodialysis who had
no evidence of pulmonary calcification on chest X-
ray. Of the 23 patients, 14 (61%) had positive scans
utilizing technetium-99m diphosphonate (99mTc-
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DP). The finding of a positive scan correlated with
the length of time on dialysis, and a significant num-
ber of the patients with a positive scan had abnor-
mal pulmonary diffusion capacity.
Methods
Twenty-three patients with end-stage renal dis-
ease undergoing maintenance hemodialysis at
Brookdale Hospital Medical Center were studied.
All the patients on maintenance hemodialysis in our
unit were asked to participate in the study, and only
those patients consenting and able to cooperate
were included. Patients were dialyzed 15 hr/week (5
hr x 3/week) with a Travenol RSP machine and Ex-
tracorporeal 23 or 25 dialyzers. All dialysis baths
contained calcium, 2.5 mEq/liter; magnesium, 1.5
mEq/liter; and acetate, 36.6 mEq/liter; except for
patients 1 and 2 in group 1 in whom the dialysis bath
calcium was maintained at 3.5 mEq/liter. All pa-
tients were maintained on a 60-g protein, 2-g sodium
diet and were treated with oral phosphate binders.
Patients 1, 2, and 11 (group 1), who had prior para-
thyroidectomy, were treated with 0.125 mg of dihy-
drotachysterol and 1.0 g of calcium gluconate twice
a day.
Blood samples for calcium, phosphorous, magne-
sium, total protein, and albumin were obtained be-
fore dialysis and analyzed on a dual channel Techni-
con autoanalyzer the same morning [10]. Arterial
blood for pH and Pco2 were obtained before dial-
ysis and analyzed immediately on a pH M72 Radi-
ometer blood gas analyzer. Plasma bicarbonate
conceptration was determined from the Henderson-
Hasselbach equation, with a pK of 6.1 and a
solubility coefficient for Pco2 of 0.0301. Parathyroid
hormone (PTH) levels were determined with the
Immuno-Nuclear Corporation kit [11] and Searle 1195
counter on blood obtained before dialysis (normal
up to 1.5 ng/ml). Lung scans with 99nhlTcDP, a bone-
seeking radionuclide, were performed on non-
dialysis days with a Cleon 760 scanner. Fifteen mu-
licuries of 991Tc-DP were injected i.v., and the scan
was performed 2 hours later. The scans were inter-
preted as showing lung parenchymal uptake of the
radionuclide (positive) or no uptake (negative) by
one of us (J.G.) without any knowledge of the clini-
cal findings or results of pulmonary function testing.
Pulmonary function tests were performed in 15
patients 30 to 60 mm after dialysis [12] within 4
weeks of the scan. The 1-sec forced expiratory vol-
ume (FEy1), forced vital capacity (FVC), and total
lung capacity (TLC) were performed with the Pul-
mote st-Godart apparatus. Steady-state diffusion ca-
pacity (DLCO) was measured with the Collins Instru-
mentation Associates Total Diffusion Test hA ap-
paratus. Standard tables were used to predict
FEy1, FVC, TLC, and DL(() based on age, sex, and
height [13]. Results for FEY1, FVC, TLC, and DLCO
are expressed as a percent of predicted. Results for
FEVI/FVC are expressed as a direct percentage.
Statistical analyses were performed by the Wil-
conxon-Rank sum and Fisher's exact texts. All
results are expressed as the means SEM.
Tissue calcium content was determined accord-
ing to the technique previously described by Con-
tiguglia et al [14]. After being cut into small pieces,
the lung tissue was dried for 16 hours at 130° C. The
tissue was ground to a fine powder, and the fat was
extracted with ether. Tissue was again dried, re-
weighed, digested in 1 ml of boiling nitric acid for 1
hour, then diluted with 25 ml of distilled water. Cal-
cium was determined with an atomic absorption
spectrophotometer (Perkin-Elmer 290B). Results
are reported in millimoles per kilogram of fat-free
dry solids.
Lung tissue from patient 5 of group 1 was ana-
lyzed by X-ray diffraction and selected area elec-
tron diffraction by Dr. Arthur N. Rohl at the Envi-
ronmental Sciences Laboratory of the Mount Sinai
School of Medicine, Mount Sinai Hospital, New
York. The X-ray diffraction technique used was a
continuous scan at a scanning speed of 1 degree 2
thetalmin from 5 to 80 degrees 2 theta at a counting
rate of 500 counts/sec, with an X-ray diffractometer
(model Mark 4, Philips Electronics). Electron dif-
fraction was performed with a Hitachi transmission
electron microscope.
The patients were kept at the weight at which
they demonstrated orthostatic changes in blood
pressure during the period of study (blood tests,
chest X-ray, scan and pulmonary function testing).
Patients were questioned repeatedly about symp-
toms referrable to the respiratory tract; that is, the
presence of dyspnea at rest or exertion, paroxysmal
nocturnal dyspnea, or orthopnea.
Results
Clinical features, hematocrit, serum calcium,
phosphorous, and bicarbonate and PTH blood lev-
els for all patients are shown in Table 1. Based on
the results of the 9DmTcDP lung scan, we divided
patients into two groups; group 1 consisted of 14
patients with a positive scan (61%), and group 2
contained 9 patients with a negative scan. None of
the patients in either group showed lung paren-
chymal abnormality on chest X-ray. Cardiomegaly
was present in 8 patients in group I and 5 patients in
group 2. Figure 1A shows a typical positive 99mTc-
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Table 1. Clinical findings and laboratory data
Time
on
Patient Diagnosisa
Age
yr Sex
dialysis
months
Hct
%
Calcium"
mgldl
Phosphate"
mgldl
Bicarbonate"
mEq/liter
PTHe
nglml
Group 1 (positive °'mTc-DP Scan)
1 Chronic GN 23 M 83 22 9.0 7.0 15 —
2 Chronic GN 52 F 42 24 9.5 4.0 22 —
3 Chronic GN 72 M 10 23 8.0 3.7 27 4.0
4 Chronic GN 58 F 24 35 8.0 6.0 20 13.5
5 Chronic GN 60 M 36 25 9.9 4,0 25 2.8
6 Chronic GN 56 M 22 25 10.0 8.0 24 9.0
7 Membranousnephropathy 62 M 23 30 9.0 7.0 22 13.5
8 MesangiocapillaryGN 56 M 64 22 8.0 4.7 18 4.5
9 Membranousnephropathy 58 F 26 26 9.1 5.6 14 7.0
10 Nephrosclerosis 66 F 49 28 8.9 5,6 19 5.3
11 Nephrosclerosis 62 F 53 20 8.4 4.4 20 —
12 Chronic GN 54 F 16 22 8.0 7.0 19 15.8
13 Diabetic nephropathy 56 M 36 35 8.0 6.0 19 3.5
14 ChronicGN 65 F 42 22 8.6 5.5 18 5.6
Mean SEM 54 3 38 5 26 1 8.7 0.2 5.6 0.4 20 0.1 7.7 1.4
Group 2 (negative °'mTc-DP Scan)
1 Focal GS 35 M 7 26 7.9 4.8 19 7.8
2 Diabetic nephropathy 73 M 7 25 8.8 4.6 17 7.6
3 Chronic GN 55 F 28 24 9.0 4.0 20 10.8
4 Chronic GN 54 F 12 21 10.0 6.0 15 6.4
5 Chronic GN 67 M 7 28 8.4 4.0 14 12.2
6 Diabetic nephropathy 75 M 4 24 8.7 4.3 23 1.1
7 Nephrosclerosis 79 M 35 24 9.3 3.7 20 3.3
8 Interstitial nephropathy 59 F 3 30 9.0 5.0 15 10.5
9 Diabetic nephropathy 66 F 3 25 9.2 4.5 17 35.7
Mean SEM 63 5 12 4 25 1 8.9 0.2 4.5 0.2 18 1 10.6 3.4
P NS <0.01 NS
NS
NS NS NS NS
a Abbreviations are: GN, glomerulonephntis; GS, glomerulosclerosis.
Mean of five determinations
Mean of two determinations
DP lung scan (patient 7, group 1) contrasted to a
negative scan in Fig. lB (patient 9, group 2).
Group-i patients were on maintenance hemo-
dialysis a significantly longer time than were group-
2 patients, 38 5 compared with 12 4 months (P
< 0.01). The mean age and sex distribution were
similar in the two groups. There were no differences
in blood pressure control, hematocrit, serum cal-
cium, phosphorous, bicarbonate, total protein, and
albumin, or arterial Pco2 in the two groups. Mean
PTH level was 7.7 1.4 ng/ml in group 1 (not in-
cluding the three patients 1, 2, and 11 who had a
subtotal parathyroidectomy 20, 28 and 12 months,
respectively, prior to this study) compared with
10.6 3.4 nglml in group 2, which was not signifi-
cantly different. Mean serum magnesium was 3.2
0.4 for group 1 (N = 5) and 3.4 0.3 mgldl in group
2 (N = 5).
Figure 2 shows the results of pulmonary function
testing in 10 patients in group 1 and 5 in group 2.
The two groups were similar as to weight (60 4 vs.
62 4 kg), height (158 3 vs. 162 4 cm), and
hemoglobin level (9.3 0.8 vs. 8.9 0.5 g/dl).
There was no statistical difference in TLC, FEy1,
FVC, and FEV1/FVC between the two groups.
DLCO, however, was impaired in 7 of the 10 patients
in group 1 compared with none in group 2 (P =
0.014). Overall, there was a negative correlation be-
tween diffusion capacity and the length of time on
dialysis (r = —0.52, P < 0.05). Although more pa-
tients in group 1 had dyspnea at rest or exertion not
explained by fluid overload or congestive heart fail-
ure compared with group 2, it was difficult to eval-
uate the significance of this finding because of the
prevalence of obstructive disease as reflected by
impairment in FEy1 and FVC in both groups (Fig.
2). Patients 7 and 8 in group 1, however, had dysp-
nea at rest with normal FEY1 and FVC but with a
decrease in DLCO of 60 and 69%, respectively. In
fact, the unexplained dyspnea in these two patients
stimulated us to carry out this study.
Postmortem examinations were performed on pa-
tient 5 of group 1 and patient 9 of group 2. X-ray
examination of the removed, deflated lung in group-
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Fig. 1. Representative ssmTcdiphosphate scans: A Positive scan (patient 5, group 1). B Negative scan (patient 9, group 2).
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Fig. 2. Results of pulmonary function tests. The open bar represents the normal range. DLCO, TLC, FEy1, and FVC are expressed as
percent of predicted. FEV1/FVC is expressed as a direct percentage. See text for explanation of abbreviations.
1 patient 5 revealed significant calcification (Fig. 3).
Histologic examination of the lung also revealed
significant calcification with increased fibrous tissue
in proximity to the calcification within the alveolar
septa (Fig. 4). Tissue calcium analysis revealed a
concentration of 356 mmoles/kg of free-fat dry sol-
ids. Both X-ray diffraction and selected area elec-
tron diffraction of the tissue from patient S (group 1)
failed to reveal any crystalline material of the cal-
cium phosphate (apatite) group. The lung tissue of
patient 9 (group 2) failed to reveal any calcification
histologically. Tissue calcium concentration in the
lung of this patient was 44 mmoles/kg of fat-free dry
solids.
Discussion
In the present series, 61% of 23 patients with end-
stage renal disease on maintenance hemodialysis
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Fig. 3. Postmortem X-ray of the lung of patient 5 of group I
Calcification of the parenchyma is demonstrated in the deflated
lung. Calcification was not visible on routine chest X-ray ante-
mortem.
were found to have a positive ssmTcDP lung scan in
the absence of visible calcification on routine radio-
graphic examination of the chest. The 61% in-
cidence of positive scans is very similar to the in-
cidence of 60 to 75% reported in autopsy series [4,
15].
Because of their high bone affinity, technetium-
99m-labeled phosphorus-based (99mTc-P) radio-
nuclides have been used to detect pulmonary calci-
fication in patients hypercalcemic from a variety of
causes [8, 16—18]. In addition, there have been sev-
eral reports dealing with the detection of pulmonary
calcification in uremic patients on maintenance dial-
ysis with 99mTc-P radionuclides [6, 7, 19, 20]. Va-
lentzas et al [19] found a positive lung scan with
these bone-seeking radionuclides in 11 of 22 uremic
patients undergoing maintenance peritoneal or he-
modialysis with a scanning technique very similar
to ours. On the other hand, Conger and Alfrey [21]
reported scanning 10 uremic patients with no posi-
tive findings, and de Graaf et al [20] noted only 1 of
30 dialysis patients with definite positive pulmonary
uptake of a ssmTcP radionuclide with subsequent
histologic examination revealing extensive calcifi-
cation. In several other patients, increased uptake
was suggested but not definite, according to these
authors. Unfortunately, Conger and Alfrey [21] nei-
ther give their exact technique for the scanning pro-
cedure nor indicate the length of time their patients
were on dialysis. De Graafet al [20] definitely used
a different technique than that used in the present
study. These investigators administered a smaller
dose and performed a 5-hour hemodialysis between
the administration of the bone-seeking radionuclide
and measurement of uptake at 6 hours.
The nature of soft tissue calcification in uremia
has been extensively investigated [14, 22, 23]. The
investigators in these studies characterized two dis-
tinct forms of calcium phosphate deposits in uremic
patients; hydroxyapatite in periarticular or arterial
calcification and an amorphous whitlockite-like
compound with a high pyrophosphate content in
visceral (heart, lung, kidney and skeletal muscle)
calcification [14, 22]. Conger and Alfrey [21] sug-
gested that ssmTcDP does not readily adsorb to the
amorphous visceral calcification, but they did note
some uptake (24%) in in vitro studies. Akmal et al
[24] demonstrated that the 99mTc-DP scan detected
muscle calcification (a visceral-type calcification) in
patients with acute renal failure due to rhabdomyo-
lysis. More recently, Buja et al [25], in an extensive
examination of the localization of ssmTcP radio-
nuclides in acute myocardial infarction in dogs,
demonstrated that tissue uptake of the radionuclide
was localized selectively to sites with elevated cal-
cium concentrations in the infarcted area of the
heart or in the necrotic muscle of the thoracotomy
incision necessary to produce the myocardial in-
farct. They found that the radionuclide was ad-
sorbed to amorphous calcium phosphate in addition
to crystalline hydroxyapatite, as well as to calcium
complexed with myofibrils and other macromole-
cules. Moreover, in in vitro studies, ssmTcpyro
phosphate bound to amorphous calcium phosphate
and hydroxyapatite equally (95 and 98%, respec-
tively). These investigators felt their findings were
consistent with the conclusion that phenomena re-
lated to calcium accumulation are primarily respon-
sible for in vivo concentration of ssmTcP radio-
nuclides [25].
In most previous reports of positive bone-seeking
radionuclide lung scans, there were also roentgeno-
graphic or histologic evidence of pulmonary calcifi-
cation [1—3, 6, 9, 16—18, 201. In the present re-
4-
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Fig. 4. Histologic appearance of the lung of patient 5 of group 1. The short arrow points to an area of calcification, and the long arrow
points to an area of increased septal fibrosis in proximity to calcium deposits. (H & E stain; x400).
port, the one patient with a positive scan autopsied
(patient 5, group 1) had extensive pulmonary calcifi-
cation on postmortem radiographic and microscop-
ic examination of the fixed lung (Fig. 4), which on
X-ray diffraction and selected electron diffraction
study was amorphous in nature. Postmortem micro-
scopic examination of the lungs of patient 9 of group
2 (negative scan) did not reveal any calcification.
Tissue calcium concentration in the lung of patient 5
of group 1 was 356 mmoles/kg of fat-free dry solids,
whereas the tissue calcium concentration in the
lung of patient 9 of group 2 was only 44 mmole s/kg
of fat-free dry solids. In the studies of Conger et al
[4] and Contiguglia et al [14], calcium concentration
in normal lung tissue was 18 2.6 and 24 8 (mean
mmoles/kg of fat free dry solids, respectively.
In the study of Conger et al [4] in hemodialyzed pa-
tients, calcium concentration in the lungs of pa-
tients who did not demonstrate histologic evidence
of calcification ranged from 13 to 51 mmoles/kg of
fat-free dry solids, whereas the calcium concentra-
tion in the lungs of patients with histologic evidence
of calcification ranged from 51 to 1475 mmoles/kg of
fat-free dry solids. The pulmonary calcium contents
of the 2 patients studied in the present series (one
with a positive scan and one with a negative scan)
are, therefore, compatible with previous findings in
chronic hemodialysis patients with and without his-
tologic evidence of pulmonary calcification. Thus,
from all of the above, it seems reasonable to suggest
that the patients with a positive 99mTc-DP scan in
the present series probably had pulmonary calcifi-
cation. In addition, the radionuclide could adsorb to
collagen in alveolar septa, as there is some evidence
suggesting uptake of bone-seeking radionuclides in
immature collagen and other macromolecules [25_
27]. Conger et al [4] noted septal thickening with
collagen in their autopsy series only in association
with pulmonary calcification, and in our patient
with pulmonary calcification noted on postmortem
examination there was an increase in collagen in
proximity to the septal calcification (Fig. 4).
The only clinical or laboratory findings that dis-
tinguished group-i from group-2 patients were that
1•
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the former had been on hemodialysis longer and a
significant number had impairment in lung diffusion
capacity. The latter finding could not be explained
by differences in hematocrit or by fluid overload
and/or congestive heart failure. Although the defect
in lung diffusion capacity correlated with the length
of time on dialysis, the finding of a positive 99mTc-
DP scan also correlated with the length of time on
dialysis, so that it seems quite likely that the defect
in diffusion capacity was related to the pulmonary
calcification (and associated scarring?). Impairment
in lung diffusion capacity was also noted by Conger
et al [4] in those patients with the most extensive
calcification on postmortem examination. The
dyspnea at rest noted in two patients in group 1
without evidence of obstructive pulmonary disease
(patients 7 and 8) is probably best explained by the
pulmonary calcification and resultant abnormality
in pulmonary diffusion. Others have also suggested
that pulmonary calcification in patients with uremia
may be the cause of respiratory symptoms [4, 7, 8,
17, 19].
The exact mechanisms responsible for soft tissue
calcification have not been elucidated. Valentzas et
al [19] emphasized the calcium x phosphorus prod-
uct in patients with chronic renal failure on dialysis,
malignancy or primary hyperparathyroidism. Their
patients with positive lung uptake of a bone-seeking
radionuclide had a statistically higher product than
those with negative scans. Conger et al [4] found
no association between the calcium x phosphorus
product and the presence of pulmonary calcification
on postmortem examination in 15 dialyzed patients.
Kraikitpanitch et al [28], studying myocardial cal-
cium deposits in azotemic dogs, found no difference
in the calcium x phosphorus product between
those with and without calcification. In our study,
both groups had similar calcium x phosphorus
products (Table 1). Serum magnesium, which may
also influence soft tissue calcification [29], was also
similar in both groups.
There is ample evidence that increased PTH lev-
els play a role in soft tissue metastatic calcification
and that this calcification may be prevented in ure-
mic animals by prior parathyroidectomy [28], sug-
gesting that secondary hyperparathyroidism, which
was present in all our patients (Table 1), is a major
factor in pulmonary calcification. One may argue
that hyperparathyroidism is not important because
patients 1, 2, and 11 of group 1 had positive scans
20, 38 and 12 months, respectively, after para-
thyroidectomy for intractable bone disease. The
abnormalities associated with secondary hyper-
parathyroidism usually resolve after parathyroid-
ectomy [30] and/or renal transplantation [31];
Aifrey et al [22] noted, however, that the high
pyrophosphate content of visceral calcifications
could prevent its mobilization even when the milieu
within which it was formed is normalized, as would
occur after transplantation.
In conclusion, the present study demonstrates
that a significant number of patients with end-stage
renal disease on maintenance hemodialysis have a
positive lung scan with the bone-seeking radio-
nuclide ssmTcDP in the absence of pulmonary ab-
normalities on chest X-ray. These patients were on
dialysis a longer period of time (usually more than
20 months) than were patients with negative scans.
Moreover, impaired lung diffusion capacity was fre-
quently observed in this group, whereas all patients
with a normal scan tested had normal diffusion ca-
pacity. Therefore, we propose that 99mTc-DP pul-
monary scintigrams might be a useful adjunct in the
evaluation of patients with end-stage renal disease,
particularly those with unexplained dyspnea.
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